This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Nov. 6, 2013



















Not an AzPA member?

Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.


 

Cutting edge: What's new in pharmaceutical R&D
By Rosemary Sparacio
It is clear that pharmaceutical companies are tackling serious diseases in therapeutic areas that heretofore were more challenging. But new technology has changed that landscape forever. And patients with diseases, like cystic fibrosis, cancer, celiac disease and Crohn's disease, now have a wide variety of drugs to look forward to in the near future. Many pharmaceutical companies are forming alliances with significant monetary investments to improve both their product lines and their bottom lines.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


AREA & ASSOCIATION NEWS


The holidays are just around the corner ...
AzPA



The holidays are coming quickly! Purchase your gift cards from the Arizona Pharmacy Foundation and support pharmacy education.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Pharmacy Packaging Solutions

Medical Packaging Inc. (MPI) is a leading manufacturer of unit-dose pharmacy packaging solutions for oral solids, liquids, and ampoules, vials and syringes.   Coupled with our exclusive Pak-EDGE™ UD Barcode Labeling Software, MPI’s solutions assist the hospital pharmacy in minimizing medication errors, increasing operational efficiency, and decreasing costs.
 


PHARMACY UPDATES


Are we doing enough to ensure the security of our nation's pharmaceutical supply chain?
PhRMA
Read what other professionals across the pharmacy and pharmaceutical profession think, then add your comments to join in the conversation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


CDC publishes new antibiotic resistance threat report
California Medical Association
Every year, more than 2 million people in the United States people become infected with bacteria that are resistant to antibiotics, and at least 23,000 people die as direct a result of these infections, according to a new report issued by the Centers for Disease Control and Prevention.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




New FDA video offers tips for recognizing rogue pharmacies
Drug Store News
The Food and Drug Administration has released a new video that warns consumers against buying drugs from rogue-Internet pharmacies, part of the ongoing effort by the agency to keep fake and contaminated drugs out of the U.S. supply chain.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA introduces plan, proposed rule for drug shortages
American Society of Health-System Pharmacists
The FDA recently rolled out a strategic plan and a proposed rule that are meant to avert drug shortages and lessen the effects of shortages when they do occur. FDA Commissioner Margaret A. Hamburg said during a media briefing this afternoon that preventing shortages is "a top priority" for FDA.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    FDA move to restrict hydrocodone products could harm patients (National Community Pharmacists Association)
Pharmacy schools turning out too many grads (Pittsburgh Post-Gazette)
Extended-release hydrocodone painkiller approved (HealthDay News)
New multiple sclerosis treatment recommendations (Medscape)
US guidelines expand potential uses of J&J TB drug (Reuters)

Don't be left behind. Click here to see what else you missed.


IN THE NEWS


Pharmacists improve outcomes for underserved diabetes patients
Pharmacy Times
Pharmacists working in teams with other healthcare professionals as part of the American Pharmacists Association Foundation's Project IMPACT: Diabetes helped to significantly improve blood-sugar control, cholesterol, blood pressure and body mass index in underserved diabetes patients, according to interim clinical results announced Oct. 24.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ISMP facilitates change through national Vaccine Error Reporting Program
American Pharmacists Association
The Institute for Safe Medication Practices has developed a national Vaccine Error Reporting Program to collect data on errors that occur with the handling of vaccine products and their administration in an effort to facilitate process changes and to provide education.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE



Chemo brain: A decade of evidence
Medscape
Cognitive dysfunction is a recognized entity that can occur in cancer patients treated with chemotherapy or radiotherapy. Medscape Oncology spoke with Dr. Jeffrey S. Wefel, section chief of neuropsychology at MD Anderson Cancer Center, Houston, for an overview of what the evidence shows about the condition popularly known as "chemo brain."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Probiotics in practice: What's the evidence?
Pharmacy Practice News
Is it time for infectious disease pharmacists to include recommendations for probiotics in their antibiotic stewardship and discharge planning efforts? The use of probiotics has certainly caught on as a means of alleviating a variety of gastrointestinal afflictions, experts note. However, a lack of clinical evidence regarding their efficacy remains, according to a presentation at the 2013 Digestive Disease Week meeting.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword PROBIOTICS.




FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Serotonin syndrome risk from triptans, antidepressants downplayed
Pharmacy Practice News
A new analysis adds to the evidence that coprescribing triptans and selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors is safe.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Food for thought: How are you perceived professionally?
By Karen Childress
How you are perceived as a healthcare professional makes a difference. Fair or not, we're all judged based on how we present ourselves. Being perceived professionally goes way beyond the wardrobe we choose, however.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
FDA move to restrict hydrocodone products could harm patients
National Community Pharmacists Association
NCPA CEO B. Douglas Hoey issued a statement in response to news that the FDA is moving to reschedule hydrocodone-containing products from Schedule III to Schedule II.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MEDICATION UPDATES


A new clinical report: Drugs and the breast-feeding mother
Medscape
Many breast-feeding women are advised to stop taking necessary medications or to discontinue nursing because of potential harmful effects on their infants. The reality is that few medications are contraindicated in breast-feeding mothers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Serotonin syndrome risk from triptans, antidepressants downplayed
Pharmacy Practice News
A new analysis adds to the evidence that coprescribing triptans and selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors is safe.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: Ponatinib users not responding to drug should stop treatment
American Society of Health-System Pharmacists
The FDA recently announced that its recent investigation of ponatinib use since the drug's approval last December has revealed an increased frequency of blood clots and narrowing of blood vessels in patients. In response to a request from the agency, Ariad Pharmaceuticals Inc. announced that the company is temporarily suspending the marketing and commercial distribution of ponatinib, which is known by the brand name Iclusig.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Nov. 6, 2013
Oct. 30, 2013
Oct. 23, 2013
Oct. 16, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063